Left Ventricular Concentric Geometry During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients

Abstract—Left ventricular (LV) mass and geometry predict risk for cardiovascular events in hypertension. Regression of LV hypertrophy (LVH) may imply an important prognostic significance. The relation between changes in LV geometry during antihypertensive treatment and subsequent prognosis has not yet been determined. A total of 436 prospectively identified uncomplicated hypertensive subjects with a baseline and follow-up echocardiogram (last examination 72±38 months apart) were followed for an additional 42±16 months. Their family doctor gave antihypertensive treatment. After the last follow-up echocardiogram, a first cardiovascular event occurred in 71 patients. Persistence of LVH from baseline to follow-up was confirmed as an independent predictor of cardiovascular events. Cardiovascular morbidity and mortality were significantly greater in patients with concentric (relative wall thickness ≥0.44) than in those with eccentric geometry (relative wall thickness <0.44) in patients presenting with LVH (P =0.002) and in those without LVH (P =0.002) at the follow-up echocardiogram. The incidence of cardiovascular events progressively increased from the first to the third tertile of LV mass index at follow-up (partition values 91 and 117 g/m2), but for a similar value of LV mass index it was significantly greater in those with concentric geometry (OR: 4.07; 95% CI: 1.49 to 11.14; P =0.004 in the second tertile; OR: 3.45; 95% CI: 1.62 to 7.32; P =0.001 in the third tertile; P <0.0001 in concentric versus eccentric geometry). Persistence or development of concentric geometry during follow-up may have additional prognostic significance in hypertensive patients with and without LVH.

[1]  S. Kjeldsen.  2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension , 2004, Heart Drug.

[2]  S. Priori,et al.  2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension , 2004, Heart Drug.

[3]  R. Devereux,et al.  Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. , 2003, American journal of hypertension.

[4]  R. Schmieder,et al.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. , 2003, The American journal of medicine.

[5]  T. Kurtz.  False Claims of Blood Pressure–Independent Protection by Blockade of the Renin Angiotensin Aldosterone System? , 2003, Hypertension.

[6]  E. Porteri,et al.  Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension , 2002, Journal of hypertension.

[7]  Peter Bacchetti,et al.  Peer review of statistics in medical research: the other problem , 2002, BMJ : British Medical Journal.

[8]  Dudley J Pennell,et al.  Assessment of Left Ventricular Mass by Cardiovascular Magnetic Resonance , 2002, Hypertension.

[9]  H. S. Klopfenstein,et al.  M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). , 2001, The American journal of cardiology.

[10]  G. Mancia,et al.  Midwall Mechanics Are Improved After Regression of Hypertensive Left Ventricular Hypertrophy and Normalization of Chamber Geometry , 2001, Circulation.

[11]  D. Heisey,et al.  The Abuse of Power , 2001 .

[12]  R. Devereux,et al.  Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: The LIFE Study , 2001, Journal of hypertension.

[13]  J. Hoenig,et al.  Statistical Practice The Abuse of Power: The Pervasive Fallacy of Power Calculations for Data Analysis , 2001 .

[14]  M. Muiesan,et al.  Hypertensive left ventricular hypertrophy: pathophysiological and clinical issues. , 2001, Blood pressure.

[15]  Richard B. Devereux,et al.  Left ventricular wall stresses and wall stress–mass–heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study , 2000 .

[16]  L. Lind,et al.  Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men. , 2000, Circulation.

[17]  M. Nieminen,et al.  Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study) , 2000 .

[18]  C Cosco,et al.  Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. , 2000, Hypertension.

[19]  R. Devereux,et al.  Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study. , 2000, Hypertension.

[20]  G. Mancia,et al.  Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: the RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. Reliability of M-mode Echocardiographic Studies. , 1999, Journal of hypertension.

[21]  P. Soares-da-Silva,et al.  Deficiency of renal dopaminergic-dependent natriuretic response to acute sodium load in black salt-sensitive subjects in contrast to salt-resistant subjects. , 1999, Journal of hypertension.

[22]  R. Devereux,et al.  Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. , 1999, Journal of the American College of Cardiology.

[23]  E. Frohlich.  Risk Mechanisms in Hypertensive Heart Disease , 1999 .

[24]  K. Kohara,et al.  Relation of left ventricular hypertrophy and geometry to asymptomatic cerebrovascular damage in essential hypertension. , 1999, The American journal of cardiology.

[25]  D. Rizzoni,et al.  Various ways of calculating echocardiographic left ventricular mass and their relative prognostic values , 1998, Journal of hypertension.

[26]  P. Gosse,et al.  Relationship between left ventricular mass and serum cholesterol level in the untreated hypertensive , 1998, Journal of hypertension.

[27]  P. Korner,et al.  Assessment of prevalence of left ventricular hypertrophy in hypertension. , 1998, Journal of hypertension.

[28]  P. Palatini,et al.  Left Ventricular Performance in the Early Stages of Systemic Hypertension , 1998 .

[29]  G. Lip,et al.  Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. , 1997, The American journal of cardiology.

[30]  Giuseppe Mancia,et al.  Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy , 1997 .

[31]  A. Zanchetti,et al.  Left ventricular concentric remodelling and carotid structural changes in essential hypertension , 1996, Journal of hypertension.

[32]  P. Okin,et al.  Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[33]  J. Schwartz,et al.  Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. , 1996, Journal of the American College of Cardiology.

[34]  G. Reboldi,et al.  Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. , 1996, The American journal of cardiology.

[35]  E. Porreca,et al.  Vascular changes in hypertensive patients with different left ventricular geometry , 1995, Journal of hypertension.

[36]  D. Rizzoni,et al.  Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment , 1995, Journal of hypertension.

[37]  G. Reboldi,et al.  Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. , 1995, Journal of the American College of Cardiology.

[38]  D. Levy,et al.  Prognosis of left ventricular geometric patterns in the Framingham Heart Study. , 1995, Journal of the American College of Cardiology.

[39]  H. Matsuoka,et al.  Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension , 1995, Journal of hypertension.

[40]  D. Levy,et al.  Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. , 1994, Circulation.

[41]  S. Goodman,et al.  The Use of Predicted Confidence Intervals When Planning Experiments and the Misuse of Power When Interpreting Results , 1994, Annals of Internal Medicine.

[42]  P. Ganz,et al.  Hypertension and Left Ventricular Hypertrophy Are Associated With Impaired Endothelium‐Mediated Relaxation in Human Coronary Resistance Vessels , 1993, Circulation.

[43]  J. Laragh,et al.  Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. , 1992, Journal of the American College of Cardiology.

[44]  K. Pennert,et al.  Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. , 1992, American journal of hypertension.

[45]  J. Laragh,et al.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. , 1991, Annals of internal medicine.

[46]  J. Laragh,et al.  Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. , 1986, Annals of internal medicine.

[47]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[48]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[49]  T. Cottle.  The Life Study , 1973 .

[50]  W. Kannel,et al.  Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. , 1969, Annals of internal medicine.